Novel Biologics In US Might Not Start Getting Suffixes Until August

In January, the US FDA finalized a guidance that changes the way biologic products should be named. So far, the agency hasn't been following it.

Over the course of a week last month, FDA approved three novel biologics – Genentech Inc.'s multiple sclerosis treatment...